Indication

Premenstrual dysphoric disorder

Premenstrual dysphoric disorder is a severe, cyclical neuroendocrine and affective condition affecting individuals during their reproductive years. Read more about Premenstrual dysphoric disorder

144 drugs 94 manufacturers

Advertisement

Drugs that treat it

Common Premenstrual dysphoric disorder therapies.

Showing 1–9 of 144 drugs

FLUOXETINE HCL

ANTIDEPRESSANTS·MAJOR DEPRESSIVE DISORDER·+5
LEGACY PHARMACE
Filter & compare in the drug finder →Opens the drug finder with Premenstrual dysphoric disorder preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Premenstrual dysphoric disorder.

Premenstrual dysphoric disorder is a severe, cyclical neuroendocrine and affective condition affecting individuals during their reproductive years.

It is characterized by disabling psychological and somatic symptoms—predominantly marked irritability, depressed mood, affective lability, anxiety, fatigue, and physical discomfort—that emerge predictably during the late luteal phase of the menstrual cycle and resolve shortly after menses begins.

Pathophysiologically, the disorder involves an atypical central nervous system sensitivity to normal physiological fluctuations in ovarian steroids, leading to secondary dysregulation of central serotonergic signaling and GABA-A receptor modulation by neurosteroids such as allopregnanolone.

Personalize your experience

Follow Premenstrual dysphoric disorder and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it